VALMT Stock Analysis: Valmet | HE
Specialty Industrial Machinery | HE, Finland | Market Cap: 5.066m EUR | 12M Return: -0.1% | FI4000074984 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 9.37M
EPS Trend: -87.0%
Qual. Beats: 0
Rev. Trend: -82.0%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Valmet Oyj (VALMT) is a Finnish process technology and engineering company that supplies equipment, automation, and services to the pulp, paper, and energy industries across global markets. The company operates through two main segments: Process Performance Solutions, which focuses on flow control technologies and automation systems, and Biomaterial Solutions and Services, which delivers full production lines, key process islands, and lifecycle services for producers of pulp, paper, packaging, tissue, and bioenergy. Its product portfolio includes distributed control systems, analyzers, valves, pumps, industrial internet applications, as well as digital solutions for remote monitoring and predictive maintenance. Valmet serves a diverse customer base spanning pulp, board and paper, energy, biomaterials and fuel, chemical, and mineral sectors, and is headquartered in Espoo, Finland, with origins in 1791.
Valmet is classified within the Industrials sector and competes in the capital equipment and process solutions industry that supplies machinery, automation, and lifecycle services to industrial manufacturers. Companies in this space typically generate revenue across three streams: new equipment sales, aftermarket parts and services, and modernization/rebuild projects, with the aftermarket segment often providing recurring and higher-margin income. Valmets focus on sustainability-related offerings, such as energy and water efficiency improvements and emissions reductions, aligns its business model with the broader industrial transition toward circular and low-carbon production.
- Biomaterial Solutions demand rises on sustainable packaging and bioenergy growth
- Services revenue expands margins with recurring lifecycle contracts
- China pulp and paper capex weakness pressures order intake
| Net Income: 300.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -2.71 > 1.0 |
| NWC/Revenue: 6.66% < 20% (prev 5.05%; Δ 1.61% < -1%) |
| CFO/TA 0.06 > 3% & CFO 384.0m > Net Income 300.0m |
| Net Debt (1.13b) to EBITDA (676.0m): 1.68 < 3 |
| Current Ratio: 1.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (187.5m) vs 12m ago 1.80% < -2% |
| Gross Margin: 25.38% > 18% (prev 28.11%; Δ -2.73% > 0.5%) |
| Asset Turnover: 79.11% > 50% (prev 77.82%; Δ 1.30% > 0%) |
| Interest Coverage Ratio: 6.91 > 6 (EBIT TTM 470.0m / Interest Expense TTM 68.0m) |
| A: 0.05 (Total Current Assets 2.99b - Total Current Liabilities 2.63b) / Total Assets 6.73b |
| B: 0.15 (Retained Earnings 1.03b / Total Assets 6.73b) |
| C: 0.07 (EBIT TTM 470.0m / Avg Total Assets 6.74b) |
| D: 0.59 (Book Value of Equity 2.49b / Total Liabilities 4.23b) |
| Altman-Z'' = 1.93 = BBB |
| DSRI: 1.04 (Receivables 1.12b/1.06b, Revenue 5.33b/5.25b) |
| GMI: 1.11 (GM 28.11% / 25.38%) |
| AQI: 0.97 (AQ_t 0.45 / AQ_t-1 0.46) |
| SGI: 1.02 (Revenue 5.33b / 5.25b) |
| TATA: -0.01 (NI 300.0m - CFO 384.0m) / TA 6.73b) |
| Beneish M = -2.91 (Cap -4..+1) = A |
As of October 09, 2026, the stock is trading at EUR 26.24 with a total of 264,510 shares traded. Over the past week, the price has changed by -4.58%, over one month by -5.91%, over three months by +29.56% and over the past year by -0.09%.
Current recommended Stop Loss: 25.50 (which is 2.8% or 1.3 ATR below the current price).
Valmet has no consensus analysts rating.
P/E Trailing = 16.8712
P/S = 0.9504
P/B = 2.104
Revenue TTM = 5.33b EUR
EBIT TTM = 470.0m EUR
EBITDA TTM = 676.0m EUR
Long Term Debt = 1.06b EUR (from longTermDebt, last quarter)
Short Term Debt = 392.0m EUR (from shortTermDebt, last quarter)
Debt = 1.75b EUR (from shortLongTermDebtTotal, last quarter) + Leases 173.0m
Net Debt = 1.13b EUR (calculated: Debt 1.75b - CCE 620.0m)
Enterprise Value = 6.20b EUR (5.07b + Debt 1.75b - CCE 620.0m)
Interest Coverage Ratio = 6.91 (Ebit TTM 470.0m / Interest Expense TTM 68.0m)
EV/FCF = 20.88x (Enterprise Value 6.20b / FCF TTM 297.0m)
FCF Yield = 4.79% (FCF TTM 297.0m / Enterprise Value 6.20b)
FCF Margin = 5.57% (FCF TTM 297.0m / Revenue TTM 5.33b)
Net Margin = 5.63% (Net Income TTM 300.0m / Revenue TTM 5.33b)
Gross Margin = 25.38% ((Revenue TTM 5.33b - Cost of Revenue TTM 3.98b) / Revenue TTM)
Gross Margin QoQ = 27.30% (prev 24.92%)
Tobins Q-Ratio = 0.92 (Enterprise Value 6.20b / Total Assets 6.73b)
Interest Expense / Debt = 3.88% (Interest Expense 68.0m / Debt 1.75b)
Taxrate = 29.05% (122.0m / 420.0m)
NOPAT = 333.5m (EBIT 470.0m * (1 - 29.05%))
Current Ratio = 1.13 (Total Current Assets 2.99b / Total Current Liabilities 2.63b)
Debt / Equity = 0.70 (Debt 1.75b / totalStockholderEquity, last quarter 2.49b)
Debt / EBITDA = 1.68 (Net Debt 1.13b / EBITDA 676.0m)
Debt / FCF = 3.82 (Net Debt 1.13b / FCF TTM 297.0m)
Total Stockholder Equity = 2.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.45% (Net Income 300.0m / Total Assets 6.73b)
RoE = 12.07% (Net Income TTM 300.0m / Total Stockholder Equity 2.49b)
RoCE = 13.24% (EBIT 470.0m / Capital Employed (Equity 2.49b + L.T.Debt 1.06b))
RoIC = 7.89% (NOPAT 333.5m / Invested Capital 4.22b)
WACC = 6.55% (E(5.07b)/V(6.82b) * Re(7.87%) + D(1.75b)/V(6.82b) * Rd(3.88%) * (1-Tc(0.29)))
Discount Rate = 7.87% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 52.86 | Cagr: 0.81%
[DCF] Terminal Value 73.10% ; FCFF base≈370.2m ; Y1≈324.6m ; Y5≈262.3m
[DCF] Fair Price = 16.70 (EV 4.21b - Net Debt 1.13b = Equity 3.08b / Shares 184.2m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -87.01 | EPS CAGR: -9.60% | SUE: -0.11 | # QB: 0
Revenue Correlation: -82.04 | Revenue CAGR: -1.90% | SUE: 1.76 | # QB: 2
EPS current Quarter (2026-09-30): EPS=0.59 | Chg30d=-0.34% | Revisions=+50% | Analysts=5
EPS current Year (2026-12-31): EPS=2.15 | Chg30d=+0.08% | Revisions=+62% | GrowthEPS=+17.9% | GrowthRev=+2.7%
EPS next Year (2027-12-31): EPS=2.36 | Chg30d=-0.07% | Revisions=+62% | GrowthEPS=+9.8% | GrowthRev=+1.4%
[Analyst] Revisions Ratio: +81% (up=13, down=0)